

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | presynaptic membrane assembly (GO:0097105) | 6.47409800 |
| 2 | postsynaptic membrane organization (GO:0001941) | 5.89811395 |
| 3 | presynaptic membrane organization (GO:0097090) | 5.71424106 |
| 4 | neuronal action potential propagation (GO:0019227) | 5.32391992 |
| 5 | pyrimidine nucleobase catabolic process (GO:0006208) | 5.26946553 |
| 6 | neuron cell-cell adhesion (GO:0007158) | 5.15410665 |
| 7 | synaptic vesicle maturation (GO:0016188) | 4.91097592 |
| 8 | endothelium development (GO:0003158) | 4.85414177 |
| 9 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.67544095 |
| 10 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.62536435 |
| 11 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.52470312 |
| 12 | central nervous system myelination (GO:0022010) | 4.45539390 |
| 13 | axon ensheathment in central nervous system (GO:0032291) | 4.45539390 |
| 14 | nucleobase catabolic process (GO:0046113) | 4.28520001 |
| 15 | glutamate secretion (GO:0014047) | 4.26250466 |
| 16 | vocalization behavior (GO:0071625) | 4.19522244 |
| 17 | cell migration in hindbrain (GO:0021535) | 4.11210537 |
| 18 | protein localization to synapse (GO:0035418) | 4.08338662 |
| 19 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.01029972 |
| 20 | righting reflex (GO:0060013) | 3.99894044 |
| 21 | exploration behavior (GO:0035640) | 3.87790553 |
| 22 | synaptic vesicle exocytosis (GO:0016079) | 3.84768731 |
| 23 | cranial nerve morphogenesis (GO:0021602) | 3.81848611 |
| 24 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.81555124 |
| 25 | regulation of pigment cell differentiation (GO:0050932) | 3.76732306 |
| 26 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.69181754 |
| 27 | regulation of synapse structural plasticity (GO:0051823) | 3.67210544 |
| 28 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.66894472 |
| 29 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.66498530 |
| 30 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.61288070 |
| 31 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.59411175 |
| 32 | neurotransmitter secretion (GO:0007269) | 3.56593556 |
| 33 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.54589622 |
| 34 | dendritic spine morphogenesis (GO:0060997) | 3.54423402 |
| 35 | omega-hydroxylase P450 pathway (GO:0097267) | 3.49032125 |
| 36 | glutamate receptor signaling pathway (GO:0007215) | 3.48499775 |
| 37 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.45440372 |
| 38 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.43210885 |
| 39 | regulation of synaptic vesicle transport (GO:1902803) | 3.42070080 |
| 40 | exogenous drug catabolic process (GO:0042738) | 3.39009545 |
| 41 | * positive regulation of synapse assembly (GO:0051965) | 3.38799487 |
| 42 | auditory behavior (GO:0031223) | 3.38203618 |
| 43 | locomotory exploration behavior (GO:0035641) | 3.37380031 |
| 44 | amino sugar catabolic process (GO:0046348) | 3.35442460 |
| 45 | transmission of nerve impulse (GO:0019226) | 3.34129953 |
| 46 | * positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.28702305 |
| 47 | facial nerve structural organization (GO:0021612) | 3.24025336 |
| 48 | dendrite morphogenesis (GO:0048813) | 3.22391319 |
| 49 | neuron recognition (GO:0008038) | 3.21641683 |
| 50 | drug catabolic process (GO:0042737) | 3.20839442 |
| 51 | limb bud formation (GO:0060174) | 3.20507216 |
| 52 | positive regulation of synapse maturation (GO:0090129) | 3.20181032 |
| 53 | cranial nerve structural organization (GO:0021604) | 3.19980700 |
| 54 | synaptic vesicle endocytosis (GO:0048488) | 3.17450408 |
| 55 | startle response (GO:0001964) | 3.17294585 |
| 56 | layer formation in cerebral cortex (GO:0021819) | 3.17294172 |
| 57 | membrane depolarization during action potential (GO:0086010) | 3.11070432 |
| 58 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.10032441 |
| 59 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.09270451 |
| 60 | membrane assembly (GO:0071709) | 3.08492595 |
| 61 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.06559454 |
| 62 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.05795508 |
| 63 | L-amino acid import (GO:0043092) | 3.05189858 |
| 64 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.04401886 |
| 65 | * positive regulation of dendritic spine development (GO:0060999) | 3.02893805 |
| 66 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.01803118 |
| 67 | fear response (GO:0042596) | 3.01282938 |
| 68 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.00856085 |
| 69 | regulation of respiratory system process (GO:0044065) | 2.96138553 |
| 70 | negative regulation of neurotransmitter transport (GO:0051589) | 2.95340649 |
| 71 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.94687800 |
| 72 | neurotransmitter transport (GO:0006836) | 2.93290003 |
| 73 | synaptic transmission, glutamatergic (GO:0035249) | 2.93287531 |
| 74 | aldehyde catabolic process (GO:0046185) | 2.93147841 |
| 75 | behavioral response to ethanol (GO:0048149) | 2.92860140 |
| 76 | serotonin metabolic process (GO:0042428) | 2.92034119 |
| 77 | regulation of respiratory gaseous exchange (GO:0043576) | 2.91838463 |
| 78 | regulation of neurotransmitter secretion (GO:0046928) | 2.91359009 |
| 79 | negative regulation of dendrite development (GO:2000171) | 2.90532658 |
| 80 | behavioral fear response (GO:0001662) | 2.89688809 |
| 81 | behavioral defense response (GO:0002209) | 2.89688809 |
| 82 | response to folic acid (GO:0051593) | 2.89527509 |
| 83 | * regulation of dendritic spine morphogenesis (GO:0061001) | 2.87993060 |
| 84 | sympathetic nervous system development (GO:0048485) | 2.87726386 |
| 85 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.87572630 |
| 86 | * positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.87267292 |
| 87 | * membrane depolarization (GO:0051899) | 2.85398946 |
| 88 | * regulation of synapse assembly (GO:0051963) | 2.84705386 |
| 89 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.84394192 |
| 90 | neuron-neuron synaptic transmission (GO:0007270) | 2.82275363 |
| 91 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.81487685 |
| 92 | pattern specification involved in kidney development (GO:0061004) | 2.81305347 |
| 93 | cardiac ventricle formation (GO:0003211) | 2.81269935 |
| 94 | positive regulation of amino acid transport (GO:0051957) | 2.81136737 |
| 95 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.80454193 |
| 96 | N-acetylneuraminate metabolic process (GO:0006054) | 2.80450188 |
| 97 | central nervous system neuron axonogenesis (GO:0021955) | 2.75122727 |
| 98 | regulation of glutamate secretion (GO:0014048) | 2.75026536 |
| 99 | regulation of synaptic plasticity (GO:0048167) | 2.74476628 |
| 100 | regulation of axon guidance (GO:1902667) | 2.74349708 |
| 101 | axon extension (GO:0048675) | 2.74145031 |
| 102 | neuromuscular process controlling balance (GO:0050885) | 2.73963449 |
| 103 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.73714685 |
| 104 | behavioral response to nicotine (GO:0035095) | 2.72562163 |
| 105 | establishment of mitochondrion localization (GO:0051654) | 2.72044202 |
| 106 | amino acid import (GO:0043090) | 2.71780780 |
| 107 | synapse assembly (GO:0007416) | 2.71450745 |
| 108 | oxidative demethylation (GO:0070989) | 2.71172799 |
| 109 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.70843390 |
| 110 | positive regulation of protein kinase C signaling (GO:0090037) | 2.69700746 |
| 111 | behavioral response to cocaine (GO:0048148) | 2.69455643 |
| 112 | response to auditory stimulus (GO:0010996) | 2.69255072 |
| 113 | regulation of neurotransmitter transport (GO:0051588) | 2.69093916 |
| 114 | epithelial cell differentiation involved in kidney development (GO:0035850) | 2.68940159 |
| 115 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.68030201 |
| 116 | developmental pigmentation (GO:0048066) | 2.67533563 |
| 117 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.67526257 |
| 118 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.65964029 |
| 119 | L-phenylalanine catabolic process (GO:0006559) | 2.65964029 |
| 120 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.65814221 |
| 121 | keratinocyte development (GO:0003334) | 2.65612223 |
| 122 | organ growth (GO:0035265) | 2.65362795 |
| 123 | regulation of penile erection (GO:0060405) | 2.62357093 |
| 124 | regulation of neurotransmitter levels (GO:0001505) | 2.62162525 |
| 125 | nephron epithelium development (GO:0072009) | 2.61779586 |
| 126 | * regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.61120800 |
| 127 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 2.60689650 |
| 128 | * regulation of dendritic spine development (GO:0060998) | 2.60633185 |
| 129 | retina layer formation (GO:0010842) | 2.59875926 |
| 130 | oligodendrocyte differentiation (GO:0048709) | 2.58745431 |
| 131 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.58733286 |
| 132 | regulation of vesicle fusion (GO:0031338) | 2.57642287 |
| 133 | gamma-aminobutyric acid transport (GO:0015812) | 2.57518463 |
| 134 | * short-term memory (GO:0007614) | 2.57238434 |
| 135 | reflex (GO:0060004) | 2.56931064 |
| 136 | positive regulation of meiosis (GO:0045836) | 2.56404745 |
| 137 | protein heterotetramerization (GO:0051290) | 2.55979004 |
| 138 | lymphoid progenitor cell differentiation (GO:0002320) | 2.54661505 |
| 139 | cerebellar granule cell differentiation (GO:0021707) | 2.54627322 |
| 140 | * positive regulation of membrane potential (GO:0045838) | 2.53702338 |
| 141 | epithelial cilium movement (GO:0003351) | 2.53603373 |
| 142 | mechanosensory behavior (GO:0007638) | 2.52659123 |
| 143 | uronic acid metabolic process (GO:0006063) | 2.52450122 |
| 144 | glucuronate metabolic process (GO:0019585) | 2.52450122 |
| 145 | axonal fasciculation (GO:0007413) | 2.51503317 |
| 146 | negative regulation of protein localization to cell surface (GO:2000009) | 2.51475470 |
| 147 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.51203071 |
| 148 | DNA ligation (GO:0006266) | 2.47983083 |
| 149 | * regulation of postsynaptic membrane potential (GO:0060078) | 2.47129107 |
| 150 | cilium movement (GO:0003341) | 2.46883985 |
| 151 | positive regulation of meiotic cell cycle (GO:0051446) | 2.46707310 |
| 152 | regulation of protein kinase A signaling (GO:0010738) | 2.46597742 |
| 153 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.46331621 |
| 154 | adult walking behavior (GO:0007628) | 2.44501456 |
| 155 | GTP biosynthetic process (GO:0006183) | 2.42717884 |
| 156 | long-term memory (GO:0007616) | 2.41124586 |
| 157 | positive regulation of action potential (GO:0045760) | 2.40571074 |
| 158 | neuron remodeling (GO:0016322) | 2.40119345 |
| 159 | regulation of timing of cell differentiation (GO:0048505) | 2.38881249 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.88981067 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.79398387 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.33588704 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.32229217 |
| 5 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.84893955 |
| 6 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.79510920 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.78493558 |
| 8 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.69835365 |
| 9 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.65380198 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.54493092 |
| 11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.54493092 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.54301702 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.52153792 |
| 14 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.43947755 |
| 15 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.43272589 |
| 16 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.40383016 |
| 17 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.40230620 |
| 18 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.36605849 |
| 19 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.36548339 |
| 20 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.24789903 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.10034855 |
| 22 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 2.09710533 |
| 23 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.04461325 |
| 24 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.01952148 |
| 25 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.99670858 |
| 26 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.97850793 |
| 27 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.94965009 |
| 28 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.94597182 |
| 29 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.92281962 |
| 30 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.91794991 |
| 31 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.90223570 |
| 32 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.89698605 |
| 33 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.88705604 |
| 34 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.86305937 |
| 35 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.80940244 |
| 36 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.74186033 |
| 37 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.73308171 |
| 38 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.67192630 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.66978810 |
| 40 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.65427655 |
| 41 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.63638065 |
| 42 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.63472461 |
| 43 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.61479436 |
| 44 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.61479436 |
| 45 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.61148554 |
| 46 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.58154524 |
| 47 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.57144111 |
| 48 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.52399195 |
| 49 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.51450390 |
| 50 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.50013581 |
| 51 | VDR_22108803_ChIP-Seq_LS180_Human | 1.48166142 |
| 52 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.46118942 |
| 53 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.45657836 |
| 54 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.44881630 |
| 55 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.44258471 |
| 56 | FUS_26573619_Chip-Seq_HEK293_Human | 1.42334174 |
| 57 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.40893331 |
| 58 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.39278100 |
| 59 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.38453978 |
| 60 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.37507117 |
| 61 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.37496365 |
| 62 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.37366307 |
| 63 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.33815021 |
| 64 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.33775428 |
| 65 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.33424394 |
| 66 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.32672772 |
| 67 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32570534 |
| 68 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.29526089 |
| 69 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.29206353 |
| 70 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.29115872 |
| 71 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.29058926 |
| 72 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.29031461 |
| 73 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.28546049 |
| 74 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.28463250 |
| 75 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.26575335 |
| 76 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.24233195 |
| 77 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24216799 |
| 78 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.23643363 |
| 79 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.23506548 |
| 80 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.23198704 |
| 81 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.22878075 |
| 82 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.21290586 |
| 83 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.20150355 |
| 84 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.20147830 |
| 85 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.20094007 |
| 86 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.19897268 |
| 87 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.19481383 |
| 88 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.17482241 |
| 89 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.17108520 |
| 90 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.16493548 |
| 91 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.16299315 |
| 92 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.16113125 |
| 93 | AR_19668381_ChIP-Seq_PC3_Human | 1.15823547 |
| 94 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.15437002 |
| 95 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.14954520 |
| 96 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.14497386 |
| 97 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.12129799 |
| 98 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.10681988 |
| 99 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.10426706 |
| 100 | KDM2B_26808549_Chip-Seq_REH_Human | 1.10001769 |
| 101 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.09593533 |
| 102 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.09153416 |
| 103 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.09087406 |
| 104 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.08515277 |
| 105 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.08155440 |
| 106 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.08074485 |
| 107 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.07695479 |
| 108 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07128508 |
| 109 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.06877527 |
| 110 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.06801046 |
| 111 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.06185487 |
| 112 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.05359040 |
| 113 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 1.04685745 |
| 114 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.03338567 |
| 115 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.03325714 |
| 116 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.02716759 |
| 117 | AR_25329375_ChIP-Seq_VCAP_Human | 1.01969588 |
| 118 | * KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.01334832 |
| 119 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.01288006 |
| 120 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.00900820 |
| 121 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.00882721 |
| 122 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.00514744 |
| 123 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.00356279 |
| 124 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.00356279 |
| 125 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.99915248 |
| 126 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.99502141 |
| 127 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.99278631 |
| 128 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.98212253 |
| 129 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.98204758 |
| 130 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.97921968 |
| 131 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.96906548 |
| 132 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.96480249 |
| 133 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.93712972 |
| 134 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.92865036 |
| 135 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91524555 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 5.04026926 |
| 2 | MP0003136_yellow_coat_color | 4.03394527 |
| 3 | MP0009379_abnormal_foot_pigmentation | 3.95989824 |
| 4 | MP0001188_hyperpigmentation | 3.80903854 |
| 5 | MP0002822_catalepsy | 3.55939867 |
| 6 | MP0005409_darkened_coat_color | 3.35752425 |
| 7 | MP0004270_analgesia | 2.58512255 |
| 8 | MP0006292_abnormal_olfactory_placode | 2.51219177 |
| 9 | MP0004381_abnormal_hair_follicle | 2.49359855 |
| 10 | MP0002102_abnormal_ear_morphology | 2.42184748 |
| 11 | MP0001486_abnormal_startle_reflex | 2.39029005 |
| 12 | MP0003635_abnormal_synaptic_transmissio | 2.36848477 |
| 13 | MP0004859_abnormal_synaptic_plasticity | 2.34792285 |
| 14 | MP0009046_muscle_twitch | 2.34774030 |
| 15 | MP0001968_abnormal_touch/_nociception | 2.29094087 |
| 16 | MP0009745_abnormal_behavioral_response | 2.25254075 |
| 17 | MP0006276_abnormal_autonomic_nervous | 2.15213193 |
| 18 | MP0002064_seizures | 2.07046142 |
| 19 | MP0004742_abnormal_vestibular_system | 2.05976608 |
| 20 | MP0002272_abnormal_nervous_system | 2.03058976 |
| 21 | MP0005423_abnormal_somatic_nervous | 2.01360067 |
| 22 | MP0002734_abnormal_mechanical_nocicepti | 1.97687420 |
| 23 | MP0004142_abnormal_muscle_tone | 1.92338105 |
| 24 | MP0000778_abnormal_nervous_system | 1.89248928 |
| 25 | MP0003724_increased_susceptibility_to | 1.86127779 |
| 26 | MP0002067_abnormal_sensory_capabilities | 1.84621751 |
| 27 | MP0003938_abnormal_ear_development | 1.76767763 |
| 28 | MP0002572_abnormal_emotion/affect_behav | 1.74648435 |
| 29 | MP0002139_abnormal_hepatobiliary_system | 1.64889480 |
| 30 | MP0003787_abnormal_imprinting | 1.64003951 |
| 31 | MP0001986_abnormal_taste_sensitivity | 1.57918694 |
| 32 | MP0004811_abnormal_neuron_physiology | 1.57264108 |
| 33 | MP0002557_abnormal_social/conspecific_i | 1.54861880 |
| 34 | MP0002184_abnormal_innervation | 1.52343198 |
| 35 | MP0000026_abnormal_inner_ear | 1.52000005 |
| 36 | MP0001440_abnormal_grooming_behavior | 1.51987285 |
| 37 | MP0001905_abnormal_dopamine_level | 1.51772310 |
| 38 | MP0001501_abnormal_sleep_pattern | 1.50646274 |
| 39 | MP0002063_abnormal_learning/memory/cond | 1.50200578 |
| 40 | MP0004145_abnormal_muscle_electrophysio | 1.49266931 |
| 41 | MP0002736_abnormal_nociception_after | 1.47476292 |
| 42 | MP0002735_abnormal_chemical_nociception | 1.44304643 |
| 43 | MP0003303_peritoneal_inflammation | 1.42936903 |
| 44 | MP0005171_absent_coat_pigmentation | 1.41719602 |
| 45 | MP0000049_abnormal_middle_ear | 1.41153776 |
| 46 | MP0001970_abnormal_pain_threshold | 1.40334672 |
| 47 | MP0000015_abnormal_ear_pigmentation | 1.39914183 |
| 48 | MP0005187_abnormal_penis_morphology | 1.38140707 |
| 49 | MP0005551_abnormal_eye_electrophysiolog | 1.37182934 |
| 50 | MP0005085_abnormal_gallbladder_physiolo | 1.36975911 |
| 51 | MP0001529_abnormal_vocalization | 1.35647902 |
| 52 | MP0001963_abnormal_hearing_physiology | 1.35599443 |
| 53 | MP0002751_abnormal_autonomic_nervous | 1.35241439 |
| 54 | MP0008260_abnormal_autophagy | 1.33558228 |
| 55 | MP0002876_abnormal_thyroid_physiology | 1.32723207 |
| 56 | MP0000631_abnormal_neuroendocrine_gland | 1.32474500 |
| 57 | MP0002733_abnormal_thermal_nociception | 1.28331795 |
| 58 | MP0000566_synostosis | 1.27511515 |
| 59 | MP0008569_lethality_at_weaning | 1.26914250 |
| 60 | MP0002249_abnormal_larynx_morphology | 1.24411476 |
| 61 | MP0000920_abnormal_myelination | 1.22974703 |
| 62 | MP0006072_abnormal_retinal_apoptosis | 1.21582122 |
| 63 | * MP0002752_abnormal_somatic_nervous | 1.21382036 |
| 64 | MP0003633_abnormal_nervous_system | 1.17158187 |
| 65 | MP0002234_abnormal_pharynx_morphology | 1.17094972 |
| 66 | MP0009250_abnormal_appendicular_skeleto | 1.16888464 |
| 67 | MP0005174_abnormal_tail_pigmentation | 1.15813973 |
| 68 | MP0002177_abnormal_outer_ear | 1.15159829 |
| 69 | * MP0002882_abnormal_neuron_morphology | 1.12779524 |
| 70 | MP0002638_abnormal_pupillary_reflex | 1.10325514 |
| 71 | MP0001661_extended_life_span | 1.09386268 |
| 72 | MP0003879_abnormal_hair_cell | 1.08932911 |
| 73 | MP0001485_abnormal_pinna_reflex | 1.08785217 |
| 74 | MP0008875_abnormal_xenobiotic_pharmacok | 1.07531677 |
| 75 | MP0000569_abnormal_digit_pigmentation | 1.05332346 |
| 76 | * MP0003861_abnormal_nervous_system | 1.05251984 |
| 77 | MP0003631_nervous_system_phenotype | 1.03028980 |
| 78 | MP0005379_endocrine/exocrine_gland_phen | 1.01718101 |
| 79 | MP0003890_abnormal_embryonic-extraembry | 1.01494028 |
| 80 | MP0002229_neurodegeneration | 1.00878017 |
| 81 | MP0002066_abnormal_motor_capabilities/c | 1.00322829 |
| 82 | MP0000372_irregular_coat_pigmentation | 0.99512285 |
| 83 | MP0004272_abnormal_basement_membrane | 0.99241480 |
| 84 | MP0005595_abnormal_vascular_smooth | 0.97824086 |
| 85 | MP0003283_abnormal_digestive_organ | 0.96611133 |
| 86 | MP0001177_atelectasis | 0.96589923 |
| 87 | MP0003119_abnormal_digestive_system | 0.94546478 |
| 88 | MP0003329_amyloid_beta_deposits | 0.94333006 |
| 89 | MP0002069_abnormal_eating/drinking_beha | 0.93825938 |
| 90 | MP0002277_abnormal_respiratory_mucosa | 0.92843725 |
| 91 | * MP0000955_abnormal_spinal_cord | 0.91998189 |
| 92 | MP0004885_abnormal_endolymph | 0.91130969 |
| 93 | MP0000534_abnormal_ureter_morphology | 0.90863235 |
| 94 | MP0003121_genomic_imprinting | 0.89384824 |
| 95 | MP0003315_abnormal_perineum_morphology | 0.89127857 |
| 96 | MP0010386_abnormal_urinary_bladder | 0.87968740 |
| 97 | MP0005394_taste/olfaction_phenotype | 0.87258658 |
| 98 | MP0005499_abnormal_olfactory_system | 0.87258658 |
| 99 | MP0001664_abnormal_digestion | 0.86433690 |
| 100 | MP0001299_abnormal_eye_distance/ | 0.84807626 |
| 101 | MP0000537_abnormal_urethra_morphology | 0.84607717 |
| 102 | MP0001502_abnormal_circadian_rhythm | 0.83593728 |
| 103 | MP0001984_abnormal_olfaction | 0.83012102 |
| 104 | MP0005386_behavior/neurological_phenoty | 0.82680770 |
| 105 | MP0004924_abnormal_behavior | 0.82680770 |
| 106 | MP0003718_maternal_effect | 0.81595466 |
| 107 | MP0003937_abnormal_limbs/digits/tail_de | 0.80994659 |
| 108 | MP0002653_abnormal_ependyma_morphology | 0.80527755 |
| 109 | MP0004133_heterotaxia | 0.80327985 |
| 110 | MP0002909_abnormal_adrenal_gland | 0.79624891 |
| 111 | * MP0002152_abnormal_brain_morphology | 0.79576065 |
| 112 | MP0003385_abnormal_body_wall | 0.78933786 |
| 113 | MP0005253_abnormal_eye_physiology | 0.77494718 |
| 114 | MP0003195_calcinosis | 0.77331481 |
| 115 | MP0003828_pulmonary_edema | 0.77292763 |
| 116 | MP0003942_abnormal_urinary_system | 0.77149364 |
| 117 | MP0005365_abnormal_bile_salt | 0.76245828 |
| 118 | MP0003122_maternal_imprinting | 0.75170349 |
| 119 | MP0000681_abnormal_thyroid_gland | 0.74534725 |
| 120 | MP0005248_abnormal_Harderian_gland | 0.73919595 |
| 121 | MP0003632_abnormal_nervous_system | 0.73526541 |
| 122 | MP0002082_postnatal_lethality | 0.73286435 |
| 123 | MP0010770_preweaning_lethality | 0.73286435 |
| 124 | MP0005646_abnormal_pituitary_gland | 0.72871965 |
| 125 | MP0003868_abnormal_feces_composition | 0.72429587 |
| 126 | MP0005645_abnormal_hypothalamus_physiol | 0.71903156 |
| 127 | MP0005451_abnormal_body_composition | 0.71495060 |
| 128 | MP0002938_white_spotting | 0.69988448 |
| 129 | MP0010769_abnormal_survival | 0.69617062 |
| 130 | MP0008872_abnormal_physiological_respon | 0.69109923 |
| 131 | MP0008789_abnormal_olfactory_epithelium | 0.68757878 |
| 132 | MP0005195_abnormal_posterior_eye | 0.68325453 |
| 133 | MP0005623_abnormal_meninges_morphology | 0.64994992 |
| 134 | MP0002233_abnormal_nose_morphology | 0.63480032 |
| 135 | MP0001346_abnormal_lacrimal_gland | 0.63170183 |
| 136 | MP0008995_early_reproductive_senescence | 0.63035366 |
| 137 | MP0002163_abnormal_gland_morphology | 0.62628754 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.12649045 |
| 2 | Nonprogressive disorder (HP:0003680) | 3.76771252 |
| 3 | Peripheral hypomyelination (HP:0007182) | 3.69196459 |
| 4 | Absent/shortened dynein arms (HP:0200106) | 3.55774270 |
| 5 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.55774270 |
| 6 | Concave nail (HP:0001598) | 3.47891688 |
| 7 | Ulnar claw (HP:0001178) | 3.45669375 |
| 8 | Limb dystonia (HP:0002451) | 3.44378955 |
| 9 | Abnormality of secondary sexual hair (HP:0009888) | 3.40061021 |
| 10 | Abnormality of the axillary hair (HP:0100134) | 3.40061021 |
| 11 | Action tremor (HP:0002345) | 3.33483355 |
| 12 | Progressive inability to walk (HP:0002505) | 3.24476310 |
| 13 | Abnormal ciliary motility (HP:0012262) | 3.20208814 |
| 14 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.15254529 |
| 15 | Parakeratosis (HP:0001036) | 3.14614389 |
| 16 | Broad-based gait (HP:0002136) | 3.09661689 |
| 17 | Atonic seizures (HP:0010819) | 2.98350482 |
| 18 | Febrile seizures (HP:0002373) | 2.95137030 |
| 19 | Optic disc pallor (HP:0000543) | 2.85813681 |
| 20 | Sensory axonal neuropathy (HP:0003390) | 2.81522599 |
| 21 | Agitation (HP:0000713) | 2.77937913 |
| 22 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.76648441 |
| 23 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.76648441 |
| 24 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.74759588 |
| 25 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.73058507 |
| 26 | Poor eye contact (HP:0000817) | 2.72312606 |
| 27 | Attenuation of retinal blood vessels (HP:0007843) | 2.70576106 |
| 28 | Focal seizures (HP:0007359) | 2.68578613 |
| 29 | Thyroid-stimulating hormone excess (HP:0002925) | 2.65108587 |
| 30 | Thickened helices (HP:0000391) | 2.64904813 |
| 31 | Status epilepticus (HP:0002133) | 2.63397334 |
| 32 | Increased hepatocellular lipid droplets (HP:0006565) | 2.63194454 |
| 33 | Amblyopia (HP:0000646) | 2.61890350 |
| 34 | Renal Fanconi syndrome (HP:0001994) | 2.58411900 |
| 35 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.58088274 |
| 36 | Epileptiform EEG discharges (HP:0011182) | 2.55681204 |
| 37 | Hyperventilation (HP:0002883) | 2.54880403 |
| 38 | Inability to walk (HP:0002540) | 2.49843323 |
| 39 | Synostosis involving the elbow (HP:0003938) | 2.49275547 |
| 40 | Humeroradial synostosis (HP:0003041) | 2.49275547 |
| 41 | Epileptic encephalopathy (HP:0200134) | 2.48616232 |
| 42 | Absent speech (HP:0001344) | 2.48526088 |
| 43 | Impaired social interactions (HP:0000735) | 2.44132355 |
| 44 | Abnormal social behavior (HP:0012433) | 2.44132355 |
| 45 | Steppage gait (HP:0003376) | 2.42464188 |
| 46 | Exotropia (HP:0000577) | 2.42125606 |
| 47 | Gaze-evoked nystagmus (HP:0000640) | 2.41721045 |
| 48 | Hypothermia (HP:0002045) | 2.41260189 |
| 49 | Megalencephaly (HP:0001355) | 2.40334087 |
| 50 | Progressive cerebellar ataxia (HP:0002073) | 2.38952516 |
| 51 | Hepatoblastoma (HP:0002884) | 2.38853996 |
| 52 | Torticollis (HP:0000473) | 2.38213338 |
| 53 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.36587027 |
| 54 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.36013977 |
| 55 | EEG with generalized epileptiform discharges (HP:0011198) | 2.35837761 |
| 56 | Prolonged partial thromboplastin time (HP:0003645) | 2.34879700 |
| 57 | Hypsarrhythmia (HP:0002521) | 2.33921684 |
| 58 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.32843884 |
| 59 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.32486363 |
| 60 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.31447335 |
| 61 | Cutaneous finger syndactyly (HP:0010554) | 2.30209448 |
| 62 | Upper limb muscle weakness (HP:0003484) | 2.28029834 |
| 63 | Deep venous thrombosis (HP:0002625) | 2.26812874 |
| 64 | Polyphagia (HP:0002591) | 2.25656484 |
| 65 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.25030532 |
| 66 | Split foot (HP:0001839) | 2.23712261 |
| 67 | Decreased central vision (HP:0007663) | 2.21827653 |
| 68 | Fair hair (HP:0002286) | 2.18773195 |
| 69 | Abnormal eating behavior (HP:0100738) | 2.18499759 |
| 70 | Supranuclear gaze palsy (HP:0000605) | 2.18280563 |
| 71 | Gait imbalance (HP:0002141) | 2.18086105 |
| 72 | Sleep apnea (HP:0010535) | 2.17560087 |
| 73 | Dialeptic seizures (HP:0011146) | 2.17095532 |
| 74 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.15836257 |
| 75 | Stage 5 chronic kidney disease (HP:0003774) | 2.15598095 |
| 76 | Retinal dysplasia (HP:0007973) | 2.13965207 |
| 77 | Neurofibrillary tangles (HP:0002185) | 2.13408153 |
| 78 | Atelectasis (HP:0100750) | 2.11419969 |
| 79 | Restlessness (HP:0000711) | 2.10984241 |
| 80 | Dry hair (HP:0011359) | 2.10263597 |
| 81 | Myokymia (HP:0002411) | 2.09708177 |
| 82 | Esotropia (HP:0000565) | 2.09701818 |
| 83 | Intellectual disability, severe (HP:0010864) | 2.09125953 |
| 84 | Absence seizures (HP:0002121) | 2.08793193 |
| 85 | Optic nerve hypoplasia (HP:0000609) | 2.08278940 |
| 86 | Complement deficiency (HP:0004431) | 2.06780595 |
| 87 | Ankle clonus (HP:0011448) | 2.06696025 |
| 88 | Type I transferrin isoform profile (HP:0003642) | 2.06300426 |
| 89 | Protruding tongue (HP:0010808) | 2.05410646 |
| 90 | Congenital sensorineural hearing impairment (HP:0008527) | 2.05359644 |
| 91 | Drooling (HP:0002307) | 2.05106427 |
| 92 | Excessive salivation (HP:0003781) | 2.05106427 |
| 93 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.00475304 |
| 94 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.00475304 |
| 95 | Hypophosphatemic rickets (HP:0004912) | 1.99954443 |
| 96 | Abnormal sex determination (HP:0012244) | 1.99301806 |
| 97 | Sex reversal (HP:0012245) | 1.99301806 |
| 98 | Lipid accumulation in hepatocytes (HP:0006561) | 1.99107338 |
| 99 | Abnormality of the septum pellucidum (HP:0007375) | 1.97983839 |
| 100 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.97286255 |
| 101 | Cortical dysplasia (HP:0002539) | 1.96325760 |
| 102 | Cutaneous syndactyly (HP:0012725) | 1.96203440 |
| 103 | Hyperglycinemia (HP:0002154) | 1.96057133 |
| 104 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.95815650 |
| 105 | Metabolic alkalosis (HP:0200114) | 1.95773766 |
| 106 | Alacrima (HP:0000522) | 1.94297506 |
| 107 | Generalized tonic-clonic seizures (HP:0002069) | 1.93303515 |
| 108 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.93035423 |
| 109 | Flat occiput (HP:0005469) | 1.92941343 |
| 110 | Fibular aplasia (HP:0002990) | 1.92321988 |
| 111 | Obstructive sleep apnea (HP:0002870) | 1.92279886 |
| 112 | Shawl scrotum (HP:0000049) | 1.92274631 |
| 113 | Hemiparesis (HP:0001269) | 1.92024183 |
| 114 | Abnormality of binocular vision (HP:0011514) | 1.91844057 |
| 115 | Diplopia (HP:0000651) | 1.91844057 |
| 116 | Septo-optic dysplasia (HP:0100842) | 1.91680656 |
| 117 | Genital tract atresia (HP:0001827) | 1.91651788 |
| 118 | Bronchomalacia (HP:0002780) | 1.91591129 |
| 119 | Nephronophthisis (HP:0000090) | 1.91231513 |
| 120 | Absent septum pellucidum (HP:0001331) | 1.90716304 |
| 121 | Truncal ataxia (HP:0002078) | 1.90145244 |
| 122 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.89908082 |
| 123 | Spastic gait (HP:0002064) | 1.88705811 |
| 124 | Acute necrotizing encephalopathy (HP:0006965) | 1.88645652 |
| 125 | Amyotrophic lateral sclerosis (HP:0007354) | 1.87606095 |
| 126 | Hypomagnesemia (HP:0002917) | 1.87476099 |
| 127 | Glomerulonephritis (HP:0000099) | 1.87378991 |
| 128 | Abnormality of salivation (HP:0100755) | 1.87210890 |
| 129 | Abnormality of the lower motor neuron (HP:0002366) | 1.86254891 |
| 130 | Abnormality of magnesium homeostasis (HP:0004921) | 1.85517700 |
| 131 | Prolonged QT interval (HP:0001657) | 1.85126854 |
| 132 | Mitochondrial inheritance (HP:0001427) | 1.85072160 |
| 133 | Vaginal atresia (HP:0000148) | 1.83537704 |
| 134 | Onion bulb formation (HP:0003383) | 1.83476025 |
| 135 | Nasolacrimal duct obstruction (HP:0000579) | 1.81499351 |
| 136 | Volvulus (HP:0002580) | 1.80316616 |
| 137 | Cupped ear (HP:0000378) | 1.79998073 |
| 138 | 3-Methylglutaconic aciduria (HP:0003535) | 1.79981921 |
| 139 | Hyperthyroidism (HP:0000836) | 1.78638823 |
| 140 | Mutism (HP:0002300) | 1.78574618 |
| 141 | Microvesicular hepatic steatosis (HP:0001414) | 1.78322150 |
| 142 | Urinary urgency (HP:0000012) | 1.78261563 |
| 143 | Preaxial foot polydactyly (HP:0001841) | 1.77802694 |
| 144 | Abnormality of renal resorption (HP:0011038) | 1.77697874 |
| 145 | Stereotypic behavior (HP:0000733) | 1.77300020 |
| 146 | Coronal craniosynostosis (HP:0004440) | 1.77298126 |
| 147 | Dysmetria (HP:0001310) | 1.77189071 |
| 148 | Anhidrosis (HP:0000970) | 1.76762741 |
| 149 | Male pseudohermaphroditism (HP:0000037) | 1.76752416 |
| 150 | Short 4th metacarpal (HP:0010044) | 1.76706590 |
| 151 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.76706590 |
| 152 | Progressive external ophthalmoplegia (HP:0000590) | 1.76703500 |
| 153 | Midline defect of the nose (HP:0004122) | 1.76502304 |
| 154 | Bradycardia (HP:0001662) | 1.75780425 |
| 155 | Focal dystonia (HP:0004373) | 1.74839474 |
| 156 | Pachygyria (HP:0001302) | 1.73705546 |
| 157 | Abnormality of the renal medulla (HP:0100957) | 1.73630786 |
| 158 | Abnormality of dental color (HP:0011073) | 1.72420425 |
| 159 | Reduced antithrombin III activity (HP:0001976) | 1.71190309 |
| 160 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.71041212 |
| 161 | Adrenal hypoplasia (HP:0000835) | 1.70569545 |
| 162 | Hyperlipoproteinemia (HP:0010980) | 1.69605108 |
| 163 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.68741529 |
| 164 | Aplasia of the phalanges of the hand (HP:0009802) | 1.68741529 |
| 165 | Aplasia involving bones of the extremities (HP:0009825) | 1.68741529 |
| 166 | Incomplete penetrance (HP:0003829) | 1.67724588 |
| 167 | Conical tooth (HP:0000698) | 1.65944582 |
| 168 | Postural instability (HP:0002172) | 1.65737653 |
| 169 | Autism (HP:0000717) | 1.65181273 |
| 170 | Specific learning disability (HP:0001328) | 1.65056041 |
| 171 | Gastroesophageal reflux (HP:0002020) | 1.63792698 |
| 172 | Widely spaced teeth (HP:0000687) | 1.63503068 |
| 173 | Dysdiadochokinesis (HP:0002075) | 1.63362101 |
| 174 | Long nose (HP:0003189) | 1.62297476 |
| 175 | Abnormality of the labia minora (HP:0012880) | 1.62196646 |
| 176 | Bifid scrotum (HP:0000048) | 1.62141322 |
| 177 | Hypoplasia of the corpus callosum (HP:0002079) | 1.61964499 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 6.79267056 |
| 2 | TNIK | 4.32162001 |
| 3 | MKNK2 | 3.36258616 |
| 4 | MUSK | 3.09844824 |
| 5 | FES | 3.07453313 |
| 6 | TLK1 | 2.91710783 |
| 7 | STK16 | 2.54704147 |
| 8 | NEK1 | 2.38071130 |
| 9 | STK39 | 2.20717730 |
| 10 | DAPK2 | 2.12177192 |
| 11 | MAP2K7 | 1.82740970 |
| 12 | MKNK1 | 1.76807154 |
| 13 | NTRK3 | 1.75245639 |
| 14 | PNCK | 1.73794632 |
| 15 | MAPK13 | 1.73768379 |
| 16 | TYRO3 | 1.73611263 |
| 17 | PRPF4B | 1.69268632 |
| 18 | EPHA4 | 1.67216605 |
| 19 | FGR | 1.65719968 |
| 20 | OXSR1 | 1.63407141 |
| 21 | LATS2 | 1.60977578 |
| 22 | CAMK1G | 1.57148658 |
| 23 | PAK6 | 1.53091415 |
| 24 | FER | 1.50671037 |
| 25 | SRPK1 | 1.48487181 |
| 26 | BLK | 1.47153778 |
| 27 | WNK3 | 1.44040997 |
| 28 | CAMKK1 | 1.41279928 |
| 29 | CCNB1 | 1.38386271 |
| 30 | CDK19 | 1.37098774 |
| 31 | WNK1 | 1.36132243 |
| 32 | PRKD3 | 1.35225027 |
| 33 | CAMK2B | 1.30143323 |
| 34 | CAMK1D | 1.29066242 |
| 35 | GRK1 | 1.28271076 |
| 36 | BMPR1B | 1.26085882 |
| 37 | MARK1 | 1.18794867 |
| 38 | GRK7 | 1.13195211 |
| 39 | MAP3K9 | 1.12696999 |
| 40 | UHMK1 | 1.11698409 |
| 41 | FRK | 1.11581075 |
| 42 | PKN1 | 1.09880644 |
| 43 | IRAK2 | 1.09832922 |
| 44 | EIF2AK2 | 1.07512266 |
| 45 | NME2 | 1.04788412 |
| 46 | CAMK4 | 1.02187237 |
| 47 | NEK6 | 1.02082571 |
| 48 | MAP3K12 | 1.01955937 |
| 49 | SGK223 | 1.01333968 |
| 50 | SGK494 | 1.01333968 |
| 51 | GRK5 | 1.00038459 |
| 52 | TAOK1 | 0.98354330 |
| 53 | ADRBK2 | 0.98140595 |
| 54 | IRAK1 | 0.97579956 |
| 55 | PINK1 | 0.96774089 |
| 56 | YES1 | 0.96621717 |
| 57 | FGFR2 | 0.95925126 |
| 58 | CAMK1 | 0.95758264 |
| 59 | NTRK2 | 0.94217647 |
| 60 | SGK2 | 0.93208232 |
| 61 | INSRR | 0.92205902 |
| 62 | CAMK2A | 0.91651453 |
| 63 | AKT3 | 0.90194744 |
| 64 | NME1 | 0.88636555 |
| 65 | MAPK15 | 0.87945344 |
| 66 | SIK2 | 0.87143248 |
| 67 | PRKCZ | 0.87076053 |
| 68 | WNK4 | 0.86234128 |
| 69 | DAPK1 | 0.82784720 |
| 70 | CDK15 | 0.77922440 |
| 71 | NLK | 0.77670590 |
| 72 | CLK1 | 0.77015703 |
| 73 | RIPK4 | 0.75226156 |
| 74 | EPHA3 | 0.75042827 |
| 75 | CDK18 | 0.74698635 |
| 76 | MAP3K4 | 0.74646724 |
| 77 | PRKCH | 0.73229447 |
| 78 | CAMK2D | 0.72108114 |
| 79 | NEK2 | 0.71998454 |
| 80 | CSNK1G3 | 0.71997744 |
| 81 | EPHB2 | 0.71556070 |
| 82 | CSNK1G1 | 0.70515051 |
| 83 | CDK11A | 0.69752771 |
| 84 | IRAK3 | 0.68827026 |
| 85 | CSNK1A1L | 0.68688338 |
| 86 | PAK3 | 0.68561536 |
| 87 | STK11 | 0.66303397 |
| 88 | CSNK1G2 | 0.65527597 |
| 89 | PRKCE | 0.64675954 |
| 90 | PRKD2 | 0.64495647 |
| 91 | DYRK1A | 0.64282798 |
| 92 | EIF2AK3 | 0.64279521 |
| 93 | MAPKAPK5 | 0.63143108 |
| 94 | DYRK2 | 0.62557378 |
| 95 | BCR | 0.61577905 |
| 96 | CDK5 | 0.59354413 |
| 97 | MARK2 | 0.58764126 |
| 98 | PBK | 0.58594236 |
| 99 | CSK | 0.57334325 |
| 100 | ADRBK1 | 0.57239447 |
| 101 | PRKCG | 0.56537914 |
| 102 | CSNK1E | 0.56006797 |
| 103 | BMPR2 | 0.54680238 |
| 104 | ROCK2 | 0.54354017 |
| 105 | RPS6KA3 | 0.53586812 |
| 106 | ERBB2 | 0.53158258 |
| 107 | SGK3 | 0.51847648 |
| 108 | HIPK2 | 0.51370316 |
| 109 | IRAK4 | 0.51336538 |
| 110 | TIE1 | 0.50464800 |
| 111 | PLK2 | 0.50450379 |
| 112 | CAMKK2 | 0.49233094 |
| 113 | CSNK1D | 0.47870562 |
| 114 | MAPK10 | 0.47072759 |
| 115 | KSR1 | 0.46972671 |
| 116 | MINK1 | 0.46946849 |
| 117 | PRKG1 | 0.46123435 |
| 118 | MAPK12 | 0.44963330 |
| 119 | PRKAA2 | 0.44795652 |
| 120 | PRKACA | 0.44114871 |
| 121 | MAP2K4 | 0.43297859 |
| 122 | CDK3 | 0.43109560 |
| 123 | CAMK2G | 0.41915489 |
| 124 | TNK2 | 0.41562715 |
| 125 | PRKACB | 0.41388087 |
| 126 | DMPK | 0.40798766 |
| 127 | CDK14 | 0.40759184 |
| 128 | GSK3B | 0.39376655 |
| 129 | PHKG1 | 0.37884733 |
| 130 | PHKG2 | 0.37884733 |
| 131 | ICK | 0.37641017 |
| 132 | RPS6KA5 | 0.37593867 |
| 133 | MAP4K2 | 0.37321288 |
| 134 | MAPK8 | 0.36667456 |
| 135 | MAPK4 | 0.36257997 |
| 136 | PIK3CG | 0.35772585 |
| 137 | NTRK1 | 0.35352241 |
| 138 | CSNK1A1 | 0.35302418 |
| 139 | MST4 | 0.33937362 |
| 140 | ALK | 0.33603045 |
| 141 | FYN | 0.31533024 |
| 142 | TEC | 0.31179291 |
| 143 | SGK1 | 0.31157642 |
| 144 | DDR2 | 0.30511765 |
| 145 | PRKCB | 0.30297808 |
| 146 | STK38 | 0.30184267 |
| 147 | RET | 0.28511331 |
| 148 | PRKACG | 0.27535472 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.14722385 |
| 2 | Phototransduction_Homo sapiens_hsa04744 | 2.81443741 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.70894203 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.62254505 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.45363133 |
| 6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.42971363 |
| 7 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.32664868 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.32586697 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.26133575 |
| 10 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.21432239 |
| 11 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.17390518 |
| 12 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.16047270 |
| 13 | GABAergic synapse_Homo sapiens_hsa04727 | 2.15450244 |
| 14 | Taste transduction_Homo sapiens_hsa04742 | 2.00491431 |
| 15 | Long-term depression_Homo sapiens_hsa04730 | 1.96856395 |
| 16 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.88652279 |
| 17 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.84229616 |
| 18 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.83173934 |
| 19 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.78425524 |
| 20 | Alzheimers disease_Homo sapiens_hsa05010 | 1.74414927 |
| 21 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.72833392 |
| 22 | Ribosome_Homo sapiens_hsa03010 | 1.71751430 |
| 23 | Axon guidance_Homo sapiens_hsa04360 | 1.70815216 |
| 24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.67882436 |
| 25 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.62988870 |
| 26 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.61532078 |
| 27 | Parkinsons disease_Homo sapiens_hsa05012 | 1.61104831 |
| 28 | Protein export_Homo sapiens_hsa03060 | 1.60895760 |
| 29 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.60186355 |
| 30 | Circadian entrainment_Homo sapiens_hsa04713 | 1.56714264 |
| 31 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.48328648 |
| 32 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.43581511 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.42033952 |
| 34 | Salivary secretion_Homo sapiens_hsa04970 | 1.39801106 |
| 35 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.39162712 |
| 36 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.35519173 |
| 37 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.33785472 |
| 38 | Huntingtons disease_Homo sapiens_hsa05016 | 1.32921213 |
| 39 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.30259198 |
| 40 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.26818855 |
| 41 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.26361978 |
| 42 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.26049480 |
| 43 | Long-term potentiation_Homo sapiens_hsa04720 | 1.22525973 |
| 44 | Cocaine addiction_Homo sapiens_hsa05030 | 1.21612665 |
| 45 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.21556917 |
| 46 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.17777231 |
| 47 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.16598196 |
| 48 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.15221540 |
| 49 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.14641178 |
| 50 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.14092104 |
| 51 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.13195001 |
| 52 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.12638005 |
| 53 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.12601722 |
| 54 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.12453180 |
| 55 | Renin secretion_Homo sapiens_hsa04924 | 1.09065593 |
| 56 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.07248682 |
| 57 | Insulin secretion_Homo sapiens_hsa04911 | 1.04768780 |
| 58 | Olfactory transduction_Homo sapiens_hsa04740 | 1.04118926 |
| 59 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.98398527 |
| 60 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.98173469 |
| 61 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.96052168 |
| 62 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.95697486 |
| 63 | Melanogenesis_Homo sapiens_hsa04916 | 0.93508901 |
| 64 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.92664894 |
| 65 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.92273555 |
| 66 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.92070757 |
| 67 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.91951568 |
| 68 | Prion diseases_Homo sapiens_hsa05020 | 0.91465089 |
| 69 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.88916238 |
| 70 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.86954375 |
| 71 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.86661007 |
| 72 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.85823448 |
| 73 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.84184642 |
| 74 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.83038491 |
| 75 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.82605034 |
| 76 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.81621231 |
| 77 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.79977163 |
| 78 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.79433698 |
| 79 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.78338821 |
| 80 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.77114462 |
| 81 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.72533896 |
| 82 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.72477586 |
| 83 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.71887308 |
| 84 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.71721849 |
| 85 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.69025362 |
| 86 | Gap junction_Homo sapiens_hsa04540 | 0.67999792 |
| 87 | Histidine metabolism_Homo sapiens_hsa00340 | 0.67655012 |
| 88 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.67145256 |
| 89 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.67011363 |
| 90 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.66683465 |
| 91 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.64880682 |
| 92 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.62809712 |
| 93 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.62782546 |
| 94 | Glioma_Homo sapiens_hsa05214 | 0.62089150 |
| 95 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.61447266 |
| 96 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.60743674 |
| 97 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.60516846 |
| 98 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.60431908 |
| 99 | Sulfur relay system_Homo sapiens_hsa04122 | 0.59410655 |
| 100 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.59230216 |
| 101 | RNA polymerase_Homo sapiens_hsa03020 | 0.58395866 |
| 102 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.57434073 |
| 103 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.57236873 |
| 104 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.56117294 |
| 105 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.54939824 |
| 106 | Homologous recombination_Homo sapiens_hsa03440 | 0.54658929 |
| 107 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.54261855 |
| 108 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.54135492 |
| 109 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.52985461 |
| 110 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.51563808 |
| 111 | Asthma_Homo sapiens_hsa05310 | 0.51460074 |
| 112 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.51448289 |
| 113 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.51125244 |
| 114 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49719027 |
| 115 | Malaria_Homo sapiens_hsa05144 | 0.49232583 |
| 116 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.48321051 |
| 117 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.48308481 |
| 118 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.48225069 |
| 119 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46718309 |
| 120 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.44935438 |
| 121 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.44597063 |
| 122 | Melanoma_Homo sapiens_hsa05218 | 0.44232614 |
| 123 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.44128241 |
| 124 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.43777241 |
| 125 | Circadian rhythm_Homo sapiens_hsa04710 | 0.43629000 |
| 126 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.41801173 |
| 127 | Retinol metabolism_Homo sapiens_hsa00830 | 0.41087992 |
| 128 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.41083938 |
| 129 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.40182473 |
| 130 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.39729828 |
| 131 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39138142 |
| 132 | Lysine degradation_Homo sapiens_hsa00310 | 0.39103227 |
| 133 | Basal transcription factors_Homo sapiens_hsa03022 | 0.38535844 |
| 134 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.36425462 |
| 135 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.36347966 |
| 136 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.36164190 |
| 137 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.35523381 |
| 138 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.35179693 |
| 139 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.35004385 |
| 140 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.34710160 |
| 141 | ABC transporters_Homo sapiens_hsa02010 | 0.34340578 |
| 142 | Alcoholism_Homo sapiens_hsa05034 | 0.34209000 |
| 143 | Purine metabolism_Homo sapiens_hsa00230 | 0.33138381 |
| 144 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.33007062 |
| 145 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.32369119 |
| 146 | Metabolic pathways_Homo sapiens_hsa01100 | 0.32105102 |
| 147 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.31906062 |

